GlassScriptPhysician profile
Mary Eaccarino
NPI 1174735054
$2,255.59
in general payments reported to CMS, 2019-2025
28 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $69.33 · 2021: $358 · 2022: $357 · 2023: $510 · 2024: $250 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.05 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $793.07 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Mayne Pharma Commercial LLC | $262.08 | 2022-2025 | |
| Organon LLC | $187.94 | 2021-2025 | Nexplanon |
| Minerva Surgical, INC | $140.09 | 2019 | |
| Astellas Pharma US INC | $113.53 | 2023-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $85.09 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $73.92 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Axsome Therapeutics, INC. | $68.87 | 2023 | Auvelity |
| Hologic Sales and Service, LLC | $67.36 | 2022-2025 | Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Millicent US INC | $52.40 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Lupin INC. | $51.80 | 2019-2020 | |
| Exeltis, USA INC. | $43.32 | 2023 | Slynd |
| Exact Sciences Corporation | $32.99 | 2023-2024 | Cologuard Collection Kit |
| Gynesonics, INC. | $30.11 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $27.50 | 2023 | Balcoltra |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $23.81 | 2019 | |
| Pfizer INC. | $23.74 | 2023 | |
| Biotissue Holdings INC. | $20.00 | 2024 | |
| Coopersurgical, INC. | $19.77 | 2019 | |
| Daiichi Sankyo INC. | $19.57 | 2023 | Injectafer |
| Merck Sharp & Dohme LLC | $18.41 | 2019 | |
| Evofem Biosciences, INC. | $17.02 | 2025 | Solosec, Phexx, Phexxi |
| Roche Diagnostics Corporation | $16.86 | 2019 | |
| Allergan, INC. | $13.90 | 2019 | |
| Sage Therapeutics, LLC | $13.45 | 2019 | |
| Aspira Women'S Health INC | $13.26 | 2024 | Ova1 |
| Conmed Corporation | $13.19 | 2024 | Airseal |
| Agile Therapeutics, INC. | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Eaccarino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.